Loading...

INDSWFTLAB Ind-Swift Laboratories Ltd Capital Structure Changes Announcement

nd-S

NDSW

Ind-Swift Laboratories Ltd

(INDSWFTLAB)

2024 Announcement

Show Summary

Show Summary

Annual Compliance Report

Arbitration Update

Monitoring Agency Report

Amalgamation Hearing

Amalgamation Notice

Compliance Certificate

Employee Stock Options

Short-Term Advance

Employer Brand Award

Monitoring Agency Report

Fund Utilization Update

Code of Conduct

Director Cessation

Board Meeting Adjourned

Amalgamation Meeting

NCLT Meeting Notice

Creditors Meeting

Compliance Certificate

NCLT Order Received

Land Purchase Correction

Monitoring Report Issued

Fund Utilization Update

Funds Utilization Update

Compliance Certificate

Land Purchase Announcement

Management Reappointments

KYC Requirement

New Office Launch

AGM Notice Published

Export Performance Award

Warrant Allotment

Warrant Allotment

Annual General Meeting

NCD Delisting Notice

Auditor Appointment

Auditor Resignation

Investment Approval

Equity Pledge Release

Newspaper Advertisement Pub...

Compliance Certificate

Newspaper Publication

Preferential Issue Committe...

Compliance Submission

Newspaper Publication

Acquisition in Dubai

Compliance Update

Equity Shares Transfer

Subsidiary Incorporation

Compliance Certificate

Compliance Certificate Subm...

Equity shares sale disclosu...

Equity Shares Sold

Shares Transfer Disclosure

Release of Pledge on Shares

Disclosure of Equity Sale

Amendment Agreement

Management Change

Debenture Redemption

Business Sale Completion

Redemption Approval

Share Purchase Agreement

Management Authorization

Disclosure of Acquisition o...

Certificate Submission

Credit Rating Revision

Collaboration for Biotransf...

Compliance Certificate Subm...

Insider Trading Violation

Re-appointment and Ratifica...

E-Voting Schedule

Approval of Amalgamation Sc...

Newspaper Advertisement

Merger of Equals

Board Meeting Outcome

Publication Notice

Board Meeting Outcome

Volume Increase - Clarifica...

Financial Statements

Related Party Transactions

Financial Statements

External Links:

Data:

Ind-Swift Laboratories has allotted 2,60,00,000 Fully Convertible Warrants at Rs. 121 each on a preferential basis, following shareholder approval, to various allottees, including 80 lakh to Essix Biosciences Limited.

AI Assistant

Ind-Swift Laboratories Ltd

2024

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.